title: Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis.
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy*; D004347:Drug Interactions; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D009330:Nebulizers and Vaporizers; D011208:Powders; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D014031:Tobramycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D011208:Powders; D014031:Tobramycin